CI	Confidence interval
CTCL	Cutaneous T cell lymphoma
ICI	Immune checkpoint inhibitors
H&E	Haematoxylin and eosin
IHC	Immunohistochemistry
LCT	Large-cell transformation
mAb	Monoclonal Antibody
MF	Mycosis fungoides
OS	Overall survival
PFS	Progression-free survival
ROI	Region of interest
TP	Tumor progression
TME	Tumor microenvironment